NCT03892772View on ClinicalTrials.gov

Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

July 3, 2021

Study Completion Date

July 3, 2021

Conditions
Sleep Apnea
Interventions
DRUG

SAS0421a

treatment will be given for 3 days

DRUG

SAS0421b

treatment will be given for 3 days

DRUG

SAS0421c

treatment will be given for 3 days

DRUG

placebo

placebo will be given for 3 days

Trial Locations (2)

3168

Monash University, Clayton

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

Apnimed
All Listed Sponsors
collaborator

Apnimed

INDUSTRY

lead

Brigham and Women's Hospital

OTHER